MMR vaccine for the national immunisation programme goes to MSD
- UK Health Security Agency
- London
- Open procedure, 1 bid
- 1 May 2027 to 30 September 2029
The UK Health Security Agency (UKHSA) will buy measles, mumps and rubella (MMR) vaccine from MSD for the national immunisation programme.
UKHSA estimates it will need up to 1.12m doses over the contract, including an optional flex. Deliveries will run for 29 months, to September 2029. Bids were judged on how well they met the specification, on cost measures including vaccine, benchmark and storage costs, and on delivery risk and social value.
MSD was the only bidder in the open tender and was chosen in October 2026. The value was withheld to protect MSD's commercial interests.
Contract ends September 2029
- What
- Vaccines and immunisation products
- Supplier
- MSD
- Value
- Not published
- How it was bought
- Open procedure
- 1 bid
- Dates and next
- May 2027 to Sep 2029
- Being re-tendered now